Laboratorio Reig Jofre SA
MAD:RJF
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
2.24
3.2
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one RJF stock under the Base Case scenario is 3.08 EUR. Compared to the current market price of 2.87 EUR, Laboratorio Reig Jofre SA is Undervalued by 7%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Laboratorio Reig Jofre SA
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for RJF cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Laboratorio Reig Jofre SA
Balance Sheet Decomposition
Laboratorio Reig Jofre SA
Current Assets | 155.7m |
Cash & Short-Term Investments | 7.3m |
Receivables | 74.5m |
Other Current Assets | 73.9m |
Non-Current Assets | 200.3m |
Long-Term Investments | 9.6m |
PP&E | 94.8m |
Intangibles | 87m |
Other Non-Current Assets | 8.9m |
Current Liabilities | 104.9m |
Accounts Payable | 55m |
Other Current Liabilities | 49.9m |
Non-Current Liabilities | 41.4m |
Long-Term Debt | 29.2m |
Other Non-Current Liabilities | 12.2m |
Earnings Waterfall
Laboratorio Reig Jofre SA
Revenue
|
411.7m
EUR
|
Cost of Revenue
|
-172.8m
EUR
|
Gross Profit
|
238.9m
EUR
|
Operating Expenses
|
-222.1m
EUR
|
Operating Income
|
16.9m
EUR
|
Other Expenses
|
-5.4m
EUR
|
Net Income
|
11.5m
EUR
|
Free Cash Flow Analysis
Laboratorio Reig Jofre SA
EUR | |
Free Cash Flow | EUR |
RJF Profitability Score
Profitability Due Diligence
Laboratorio Reig Jofre SA's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
Score
Laboratorio Reig Jofre SA's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
RJF Solvency Score
Solvency Due Diligence
Laboratorio Reig Jofre SA's solvency score is 58/100. The higher the solvency score, the more solvent the company is.
Score
Laboratorio Reig Jofre SA's solvency score is 58/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
RJF Price Targets Summary
Laboratorio Reig Jofre SA
Dividends
Current shareholder yield for RJF is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
RJF Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Laboratorio Reig Jofre SA engages in the research, development, manufacture, and trade of pharmaceutical drugs. The company is headquartered in Sant Joan Despi, Barcelona and currently employs 1,152 full-time employees. The company went IPO on 2006-11-07. The Company’s activities are divided into four business divisions: Industrial Services, providing production services for third parties; Pharma, selling own pharmaceuticals under a range of brands, such as Reig Jofre, Medea, Orravan, Bioglan and Sala; Reaserch and Development (R&D) and Regulatory, including the development of indications for existing molecules, as well as generics and molecular diagnostics, among others; and Biotech, offering biopharmaceutical support services, such as analytical and process development, quality control and assurance, as well as stability studies. The firm also provides nutritional cosmetics, and food supplements, among others. The company operates worldwide in Europe, Africa, the Americas, Australia and Asia through a number of subsidiaries, including Chiesi Espana SA and Oryzon Genomics SA.
Contact
IPO
Employees
Officers
The intrinsic value of one RJF stock under the Base Case scenario is 3.08 EUR.
Compared to the current market price of 2.87 EUR, Laboratorio Reig Jofre SA is Undervalued by 7%.